FDA Clears Expanded Indications for Swift Microwave Wart Device
New data show the Swift system reduces blistering, discomfort, and recovery time while maintaining strong clinical outcomes for common and plantar warts.
New data show the Swift system reduces blistering, discomfort, and recovery time while maintaining strong clinical outcomes for common and plantar warts.
The agency has received reports of burns, scarring, fat loss, and nerve damage associated with the aesthetic devices and is urging providers to report adverse events.
The syringe redesign will first be available with select Belotero products in Europe before a phased international launch.
Cutera has launched Global Laser Aesthetics Month this October to spotlight laser technology, skin diversity, and provider and patient education.
The move addresses increased mergers, acquisitions, and regulatory scrutiny in the state's growing med spa and wellness sector.